Literature DB >> 15328112

Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae.

Paula Cerdá Zolezzi1, Leticia Millán Laplana, Carmen Rubio Calvo, Pilar Goñi Cepero, Melisa Canales Erazo, Rafael Gómez-Lus.   

Abstract

We assessed the mechanisms of resistance to macrolide-lincosamide-streptogramin B (MLS(B)) antibiotics and related antibiotics in erythromycin-resistant viridans group streptococci (n = 164) and Gemella spp. (n = 28). The macrolide resistance phenotype was predominant (59.38%); all isolates with this phenotype carried the mef(A) or mef(E) gene, with mef(E) being predominant (95.36%). The erm(B) gene was always detected in strains with constitutive and inducible MLS(B) resistance and was combined with the mef(A/E) gene in 47.44% of isolates. None of the isolates carried the erm(A) subclass erm(TR), erm(A), or erm(C) genes. The mel gene was detected in all but four strains carrying the mef(A/E) gene. The tet(M) gene was found in 86.90% of tetracycline-resistant isolates and was strongly associated with the presence of the erm(B) gene. The cat(pC194) gene was detected in seven chloramphenicol-resistant Streptococcus mitis isolates, and the aph(3')-III gene was detected in four viridans group streptococcal isolates with high-level kanamycin resistance. The intTn gene was found in all isolates with the erm(B), tet(M), aph(3')-III, and cat(pC194) gene. The mef(E) and mel genes were successfully transferred from both groups of bacteria to Streptococcus pneumoniae R6 by transformation. Viridans group streptococci and Gemella spp. seem to be important reservoirs of resistance genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328112      PMCID: PMC514728          DOI: 10.1128/AAC.48.9.3462-3467.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Incidence of mefA and mefE genes in viridans group streptococci.

Authors:  C Arpin; M H Canron; J Maugein; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes.

Authors:  T Ono; S Shiota; K Hirota; K Nemoto; T Tsuchiya; Y Miyake
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 3.  Streptococcal competence for genetic transformation: regulation by peptide pheromones.

Authors:  D A Morrison
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

4.  Characterization of a genetic element carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae.

Authors:  M Santagati; F Iannelli; M R Oggioni; S Stefani; G Pozzi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 5.  Molecular identification of Gemella species from three patients with endocarditis.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].

Authors:  C Rodríguez-Avial; M M García; I Rodríguez-Avial; J J Picazo
Journal:  Rev Esp Quimioter       Date:  1999-12       Impact factor: 1.553

7.  mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Authors:  A Tait-Kamradt; J Clancy; M Cronan; F Dib-Hajj; L Wondrack; W Yuan; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

8.  Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae.

Authors:  N Doherty; K Trzcinski; P Pickerill; P Zawadzki; C G Dowson
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.

Authors:  S Ioannidou; P T Tassios; A Kotsovili-Tseleni; M Foustoukou; N J Legakis; A Vatopoulos
Journal:  Int J Antimicrob Agents       Date:  2001-03       Impact factor: 5.283

View more
  15 in total

1.  In vivo emergence of high-level macrolide resistance in Streptococcus pneumoniae following a single dose of azithromycin.

Authors:  H C Smith-Vaughan; R L Marsh; P S Morris; A J Leach
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

2.  Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.

Authors:  Moses L Joloba; Benson R Kidenya; David P Kateete; Fred A Katabazi; Julian K Muwanguzi; Benon B Asiimwe; Simon P Alarakol; Jessica L Nakavuma; Saralee Bajaksouzian; Anne Windau; Michael R Jacobs
Journal:  Int J Antimicrob Agents       Date:  2010-05-15       Impact factor: 5.283

3.  Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).

Authors:  Ileana Cochetti; Manuela Vecchi; Marina Mingoia; Emily Tili; Maria R Catania; Aldo Manzin; Pietro E Varaldo; Maria Pia Montanari
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.

Authors:  José María Marimón; Adoración Valiente; María Ercibengoa; José M García-Arenzana; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

5.  Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible.

Authors:  Karita D Ambrose; Rebecca Nisbet; David S Stephens
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.

Authors:  Emilio Pérez-Trallero; Milagrosa Montes; Beatriz Orden; Esther Tamayo; José M García-Arenzana; José M Marimón
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

7.  Molecular epidemiology of macrolide and tetracycline resistances in commensal Gemella sp. isolates.

Authors:  Paula Cerdá Zolezzi; Pilar Goñi Cepero; Joaquim Ruiz; Leticia Millán Laplana; Carmen Rubio Calvo; Rafael Gómez-Lus
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

8.  Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers.

Authors:  M Eisenblätter; C Klaus; M W R Pletz; H Orawa; H Hahn; J Wagner; H Lode
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-30       Impact factor: 3.267

9.  The nonserotypeable pneumococcus: phenotypic dynamics in the era of anticapsular vaccines.

Authors:  R Marsh; H Smith-Vaughan; K M Hare; M Binks; F Kong; J Warning; G L Gilbert; P Morris; A J Leach
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

10.  Population structure and characterization of viridans group streptococci (VGS) isolated from the upper respiratory tract of patients in the community.

Authors:  Takuya Nakajima; Shigeyuki Nakanishi; Charlene Mason; Janice Montgomery; Paul Leggett; Motoo Matsuda; Wilson A Coulter; B Cherie Millar; Colin E Goldsmith; John E Moore
Journal:  Ulster Med J       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.